Last updated on April 2019

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Kidney Transplant Failure and Rejection
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Signed Informed Consent obtained before any study-related procedures
  • Previous dosing with imlifidase followed by kidney transplantation and participation in one of the following clinical studies: 13-HMedIdeS-02, 13-HMedIdeS-03, 14-HMedIdeS-04 or 15-HMedIdeS-06

Exclusion Criteria:

  • Individuals deemed unable to comply with the protocol
  • Inability by the judgment of the investigator to participate in the study for other reasons

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.